Literature DB >> 13940090

The elimination from plasma of intravenous heparin. An experimental study on dogs and humans.

P OLSSON, H LAGERGREN, S EK.   

Abstract

Entities:  

Keywords:  HEPARIN

Mesh：

Substances：

Year:  1963        PMID： 13940090     DOI： 10.1111/j.0954-6820.1963.tb17446.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  24 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Can lean body mass be used to reduce the dose of heparin and protamine for obese patients undergoing cardiopulmonary bypass?

Authors:  Mya S Baker; Julian R Skoyles; Frca Matt Shajar; Henry Skinner; David Richens; Ian M Mitchell
Journal:  J Extra Corpor Technol       Date:  2005-06

Review 3.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Pharmacokinetic modeling of heparin and its clinical implications.

Authors:  T J McAvoy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

Review 5.  Are We Able to Dose Protamine Accurately Yet? A Review of the Protamine Conundrum.

Authors:  Patrick Hecht; Martin Besser; Florian Falter
Journal:  J Extra Corpor Technol       Date:  2020-03

Review 6.  Intravenous heparin dosing: patterns and variations in internists' practices.

Authors:  B M Reilly; R Raschke; S Srinivas; T Nieman
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

7.  Factors affecting gentamicin assay.

Authors:  L Nilsson
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

8.  Inhibitory effect of heparin on gentamicin concentrations in blood.

Authors:  C Regamey; D Schaberg; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

9.  Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients.

Authors:  Hesham Al-Sallami; Fiona Newall; Paul Monagle; Vera Ignjatovic; Noel Cranswick; Stephen Duffull
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

10.  [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].

Authors:  H Köhler
Journal:  Klin Wochenschr       Date:  1977-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.